Crescent Grove Advisors’s JPMorgan Nasdaq Equity Premium Income ETF JEPQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Sell
38,650
-5,789
-13% -$344K 0.2% 92
2026
Q1
$2.47M Buy
+44,439
New +$2.57M 0.24% 78
2025
Q3
Sell
-55,052
Closed -$2.99M 301
2025
Q2
$2.99M Buy
55,052
+14,585
+36% +$752K 0.29% 64
2025
Q1
$2.1M Sell
40,467
-95,197
-70% -$5.3M 0.22% 74
2024
Q4
$7.71M Buy
135,664
+109,363
+416% +$6.14M 0.76% 32
2024
Q3
$1.44M Buy
26,301
+3,629
+16% +$195K 0.15% 98
2024
Q2
$1.26M Buy
22,672
+648
+3% +$34.8K 0.14% 99
2024
Q1
$1.19M Buy
22,024
+437
+2% +$22.8K 0.12% 110
2023
Q4
$1.09M Sell
21,587
-9,663
-31% -$466K 0.12% 108
2023
Q3
$1.47M Buy
+31,250
New +$1.51M 0.18% 84

Other funds holding JEPQ

Crescent Grove Advisors's JEPQ Position: Q2 2026 in Review

Crescent Grove Advisors reduced its JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) stake by 13% in Q2 2026, selling an estimated $344K and leaving 38,650 shares worth $2.38M. The position accounts for 0.2% of the portfolio, ranked #92.

Crescent Grove Advisors first reported a position in JEPQ in Q3 2023 and has held it in 10 quarters since. The position peaked at $7.71M in Q4 2024. 1,024 funds tracked by Wall St. Rank hold JEPQ as of Q2 2026.

  • Crescent Grove Advisors held 38,650 shares of JPMorgan Nasdaq Equity Premium Income ETF worth $2.38M as of Q2 2026.
  • Crescent Grove Advisors sold 5,789 JPMorgan Nasdaq Equity Premium Income ETF shares in Q2 2026, an estimated $344K.
  • JPMorgan Nasdaq Equity Premium Income ETF made up 0.2% of Crescent Grove Advisors's portfolio in Q2 2026, its #92 holding.
  • Crescent Grove Advisors first reported a position in JPMorgan Nasdaq Equity Premium Income ETF in Q3 2023 and has held it in 10 quarters since.
  • Crescent Grove Advisors's JPMorgan Nasdaq Equity Premium Income ETF position peaked at $7.71M in Q4 2024.
  • 1,024 funds tracked by Wall St. Rank held JPMorgan Nasdaq Equity Premium Income ETF as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.